iShares U.S. Pharmaceuticals ETF (IHE)
$97.36-2.82%Close
SELLBEAR · day 25
Key stats
ETF · income quality metrics
- AUM
- $1.6B
- Expense
- 0.37%
- Yield
- 1.47%
- Quality
- 54
- Beta
- 0.67
- Max DD
- -29.58%
- 1Y
- +34.26%
- 3Y
- +71.59%
- 5Y
- +74.45%
- 1W
- -1.00%
- 1M
- -4.11%
- vs SPY 1W
- -0.86%
- vs SPY 1M
- -6.61%
Industry peers
FMP comparable companies · ranked by market cap
- WCMIFirst Trust WCM International Equity ETF$1.8B$19.05
- IYMiShares U.S. Basic Materials ETF$982M$181.78
- PPHVanEck Pharmaceutical ETF$960M$110.49
- IYZiShares U.S. Telecommunications ETF$800M$42.67
- IGEiShares North American Natural Resources ETF$761M$64.29
- BKMCBNY Mellon US Mid Cap Core Equity ETF$651M$39.04
- DWMWisdomTree International Equity Fund$642M$72.87
- KSAiShares MSCI Saudi Arabia ETF$595M$36.06
- INDYiShares India 50 ETF$507M$40.53
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on IHE?
- LOPJLB’s latest quantitative signal on iShares U.S. Pharmaceuticals ETF (IHE) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is IHE in?
- iShares U.S. Pharmaceuticals ETF (IHE) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does iShares U.S. Pharmaceuticals ETF (IHE) do?
- The iShares U.S. Pharmaceuticals ETF is designed to replicate the investment performance of a benchmark index. This index consists solely of equity securities from pharmaceutical companies operating within the United States.